Medicinova (MNOV) Non Operating Investment Income (2010)
Medicinova (MNOV) posted quarterly Non Operating Investment Income of $27747.0 for Q4 2010, up 103.19% quarter-over-quarter from -$869767.0 in Q3 2010.
Medicinova (MNOV) Non Operating Investment Income (2010) Analysis & Trends
Medicinova (MNOV) has reported Non Operating Investment Income for 1 consecutive years, with $27747.0 the latest figure, recorded in Q4 2010.
- In Q4 2010, Non Operating Investment Income changed N/A year-over-year to $27747.0; the TTM figure through Sep 2011 stood at -$842020.0 (changed N/A YoY), while the FY2010 annual figure was -$785478.0, down 353.18% from the prior year.
- Non Operating Investment Income climbed to $27747.0 in Q4 2010 per MNOV's latest filing, from -$869767.0 in the prior quarter.
- Across five years, Non Operating Investment Income topped out at $64018.0 in Q2 2010 and bottomed at -$869767.0 in Q3 2010.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Investment Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Medicinova | 68.42 Mn | 68.42 Mn | 317,759.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2010 | 27,747.00 |
| Dec 31, 2010 | 27,747.00 |
| Sep 30, 2010 | -869,767.00 |
| Sep 30, 2010 | -869,767.00 |
| Jun 30, 2010 | 64,018.00 |
| Jun 30, 2010 | 64,018.00 |